NCT04000529 2025-09-30Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesNovartisPhase 1 Terminated122 enrolled
NCT04458259 2025-08-28Study of PF-07265807 in Participants With Metastatic Solid Tumors.PfizerPhase 1 Terminated88 enrolled
NCT02903914 2025-08-05Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsIncyte CorporationPhase 1 Completed260 enrolled 52 charts